---
figid: PMC7426728__fonc-10-01152-g0002
figlink: pmc/articles/PMC7426728/figure/F2/
number: F2
caption: DNA methylation regulates the PI3K/PTEN/AKT/mTOR signaling pathway in the
  resistance to therapy in cancer. (Left) PI3K induces the phosphorylation and activation
  of AKT/mTOR. This transduction signal begins with the activation of the membrane
  tyrosine kinase receptors (RTKs) or G-protein-coupled receptors, which promotes
  the change of phosphatidylinositol (4,5)-bisphosphate (PIP2) in phosphatidylinositol
  (3-5)-trisphosphate (PIP3). The activation of PI3K (phosphoinositide-3-kinase) is
  regulated by the phosphatase and tensin homolog (PTEN) by dephosphorylating PIP3
  into PIP2. (Right) We show the aberrant methylation of the PTEN, Spalt-like transcription
  factor 2 (SALL2), transforming growth factor beta-induced protein (TGFB1), and Lysine
  (K)-specific demethylase 5A (KDM5A) genes through the high expression of methyltransferase
  (DNMT3B), s-adenosylmethionine (SAM), H3K27me3, H3K9me2, and H3K4me3, promoting
  a continued activation of the PI3K/AKT/mTOR signaling pathway associated with resistance
  therapy in solid tumors. , phosphorylation; ↑, increase; ↓, decrease; , methylation,
  , radiotherapy.
pmcid: PMC7426728
papertitle: Role of DNA Methylation in the Resistance to Therapy in Solid Tumors.
reftext: Susana Romero-Garcia, et al. Front Oncol. 2020;10:1152.
pmc_ranked_result_index: '22993'
pathway_score: 0.9626007
filename: fonc-10-01152-g0002.jpg
figtitle: DNA methylation regulates the PI3K/PTEN/AKT/mTOR signaling pathway in the
  resistance to therapy in cancer
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7426728__fonc-10-01152-g0002.html
  '@type': Dataset
  description: DNA methylation regulates the PI3K/PTEN/AKT/mTOR signaling pathway
    in the resistance to therapy in cancer. (Left) PI3K induces the phosphorylation
    and activation of AKT/mTOR. This transduction signal begins with the activation
    of the membrane tyrosine kinase receptors (RTKs) or G-protein-coupled receptors,
    which promotes the change of phosphatidylinositol (4,5)-bisphosphate (PIP2) in
    phosphatidylinositol (3-5)-trisphosphate (PIP3). The activation of PI3K (phosphoinositide-3-kinase)
    is regulated by the phosphatase and tensin homolog (PTEN) by dephosphorylating
    PIP3 into PIP2. (Right) We show the aberrant methylation of the PTEN, Spalt-like
    transcription factor 2 (SALL2), transforming growth factor beta-induced protein
    (TGFB1), and Lysine (K)-specific demethylase 5A (KDM5A) genes through the high
    expression of methyltransferase (DNMT3B), s-adenosylmethionine (SAM), H3K27me3,
    H3K9me2, and H3K4me3, promoting a continued activation of the PI3K/AKT/mTOR signaling
    pathway associated with resistance therapy in solid tumors. , phosphorylation;
    ↑, increase; ↓, decrease; , methylation, , radiotherapy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - PLP2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PTEN
  - AKT2
  - AKT3
  - AKT1
  - BAD
  - DEPTOR
  - MTOR
  - MLST8
  - EIF4EBP1
  - DNMT3B
  - SALL2
  - TGFBI
  - GBL
  - BPI
  - Tamoxifen
  - H3K9me2
  - H3K4me3
  - Gefitinib
  - Erlotinib
  - Cisplatin
  - Decitabine
genes:
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AKT,
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT,
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT,
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: BAD/Bcl2>1
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: BAD/Bcl2>1celldeath
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: DEPTOR
  symbol: DEPTOR
  source: hgnc_symbol
  hgnc_symbol: DEPTOR
  entrez: '64798'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: DEPTOR
  symbol: DEPTOR
  source: hgnc_symbol
  hgnc_symbol: DEPTOR
  entrez: '64798'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: GBL
  symbol: GBL
  source: hgnc_alias_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: GBL
  symbol: GBL
  source: hgnc_alias_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: DNMT3B
  symbol: DNMT3B
  source: hgnc_symbol
  hgnc_symbol: DNMT3B
  entrez: '1789'
- word: SALL2
  symbol: SALL2
  source: hgnc_symbol
  hgnc_symbol: SALL2
  entrez: '6297'
- word: TGFBI
  symbol: TGFBI
  source: hgnc_symbol
  hgnc_symbol: TGFBI
  entrez: '7045'
chemicals:
- word: GBL
  source: MESH
  identifier: C578477
- word: BPI
  source: MESH
  identifier: C064678
- word: Tamoxifen
  source: MESH
  identifier: D013629
- word: H3K9me2
  source: MESH
  identifier: C024755
- word: H3K4me3
  source: MESH
  identifier: C024755
- word: Gefitinib
  source: MESH
  identifier: C419708
- word: Erlotinib
  source: MESH
  identifier: C400278
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Decitabine
  source: MESH
  identifier: C014347
diseases: []
figid_alias: PMC7426728__F2
redirect_from: /figures/PMC7426728__F2
figtype: Figure
---
